Mandatory Notification of Trade by Primary Insider in connection with conversion of shares

Oy Pasanen & Co, a close associate of primary insider Valter Pasanen, has converted 402,796 Nordhealth Class B shares into Class A shares, bringing the company's share capital to NOK 80,191,746 split into 45,594,543 Class A and 34,597,203 Class B shares (NOK 1.00 nominal each); Class A carries one vote and Class B ten votes. The conversion reduces the number of high‑voting Class B shares and thus the voting weight attached to the converted stake, a governance-relevant change disclosed under MAR and Norwegian securities rules. Nordhealth, a Helsinki‑based cloud healthcare SaaS provider serving c.60,000 professionals across 13,000 clinics in 30+ countries, made the mandatory notification and listed CEO/CFO contacts for further information.

Analysis

Oy Pasanen & Co, a close associate of primary insider Valter Pasanen, has converted 402,796 Nordhealth Class B shares into Class A shares; following registration the company reports share capital of NOK 80,191,746 divided into 45,594,543 Class A and 34,597,203 Class B shares at NOK 1.00 nominal each, with Class A carrying one vote and Class B ten votes. The conversion reduces the voting weight attached to the converted stake by 3,625,164 votes (9 fewer votes per share) and represents roughly 0.50% of total share capital (402,796 / 80,191,746). The transaction was disclosed under MAR Article 19 and the Norwegian Securities Trading Act Section 5-12, and external signals register neutral sentiment with a low market impact score (0.1). Nordhealth is described as a fast-growing cloud-based healthcare SaaS provider serving ~60,000 professionals across 13,000 clinics in 30+ countries with ~400 employees, so the change appears governance-technical rather than operational.

The immediate market significance is limited given the small economic size of the converted block and the reported neutral sentiment; there is no reported change to total economic ownership, only to voting class composition. The reduction in high-vote shares could modestly dilute concentrated voting power if the converted shares belonged to a controlling block, but the math implies a targeted, not transformative, governance shift. Investors should therefore view this as a disclosure to monitor for motive and follow-on filings rather than as a standalone catalyst for revaluing the business.

Key follow-up considerations are whether the conversion is one of a series (further insider conversions or transfers) and whether management provides rationale (liquidity, estate planning, or strategic governance alignment). If no further disclosures appear, the practical impact on control and strategic direction is likely minimal, but the event warrants updating internal voting-scenario models and monitoring upcoming shareholder actions.

Key Decisions for Investors

• Do not change position on the basis of this single conversion given it equals ~0.50% of share capital and market impact is scored low, treat the filing as governance-related information rather than an operational signal
• Monitor subsequent insider notifications and any company commentary to clarify motive (liquidity, estate planning or governance) and recalculate voting distributions to assess potential shifts in control ahead of shareholder votes
• If holding a large position, quantify the 3,625,164-vote reduction in your voting scenarios and consider engaging management for clarity if no explanatory disclosure appears within the next reporting cycle